Currently, there are three big categories based on tumor profile: (1) hormone receptor-positive (HR+); (2) HER2-positive breast cancer; (3) triple-negative breast cancer [23,24]. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.